← Back to Articles

Is Neurofeedback Legitimate? Evidence and Limitations

Updated 3 min readNeurofeedback
A laptop and notes arranged on a desk.

Neurofeedback is a real method for providing feedback about measured brain activity. Whether a particular program reliably improves a particular problem is a further question, and the answer depends on the protocol, population and outcome. Keeping those questions separate makes the evidence much easier to read.

In EEG neurofeedback, sensors record electrical activity at the scalp. Software processes a selected feature and makes feedback available through sound or a display. The person receives information linked to that feature while participating in the training. Showing that the feature can change is one step; showing a useful effect outside training is another.

What would count as convincing evidence?

Imagine a program that combines feedback, regular appointments, coaching and attention to sleep. Participants improve. That is encouraging, but the design has several possible explanations for the improvement.

A suitable comparison helps separate them. Sham feedback can preserve much of the experience while changing whether the reward depends on the person's targeted signal. An active comparison can test the whole program against another credible activity. Blinding reduces the chance that knowledge of the assignment shapes ratings or treatment.

Ask which question the study actually addressed. A before-and-after result is useful for describing what happened during a program. A randomized, blinded comparison provides stronger evidence about the treatment's specific contribution.

ADHD shows why the details matter

A 2025 systematic review and meta-analysis included 38 randomized trials of neurofeedback for ADHD. Its analysis of probably blinded total-symptom ratings found no meaningful overall advantage. A subgroup using standard protocols showed a small signal. The authors found no support for neurofeedback as a stand-alone ADHD treatment.

Those results deserve to shape the claim. They neither settle every neurofeedback application nor justify presenting ADHD efficacy as uniformly established. The review also has a search cutoff and limitations; it is a defined evidence synthesis, rather than a complete inventory of every later study.

The ADHD research guide examines a large sham-controlled trial and the question of individualized training. The anxiety research article addresses a different evidence base.

Device language can create confusion

“FDA registered” sounds reassuring, but registration and device listing are different from approval, clearance or authorization. The FDA's explanation makes that distinction explicit.

For a specific device, ask for its applicable regulatory status and intended use, including any authorization or exemption. Some biofeedback devices are exempt from premarket notification within stated limits; that status must be checked for the actual device and use. An assessment device's status cannot establish a treatment claim for a different product. Likewise, a billing code describes a service; it does not guarantee insurance coverage or establish effectiveness.

A useful provider conversation should make these distinctions easier to understand. Broad regulatory labels should not do the work of evidence about the proposed outcome.

What to ask before committing

Define the outcome you care about outside the session. Ask what evidence supports that outcome in people similar to you. Ask how the provider selects and reviews the protocol, handles poor-quality recordings and responds to adverse changes.

Agree on a review point, including what would justify changing or ending the program. Ask about the complete cost and whether the plan requires you to delay another form of care. If a provider supplies a response rate, request its definition and denominator, including people who discontinued.

I am the founder of Peak Brain Institute, so I have a professional connection to this service. Peak Brain describes its service as brain training and coaching. That positioning is separate from medical diagnosis or mental-health treatment. The remote-program description states that boundary, which should remain clear in any individual plan.

The strongest reason to trust a method is a claim that remains precise when you examine it. Look for a provider who can explain the evidence, its limits and the decisions that follow from your own results.

TAGS

neurofeedbackADHDEEGresearch evidence

References

  1. Westwood SJ; Aggensteiner P-M; Kaiser A; et al.; for the European ADHD Guidelines Group (2025). Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. doi:10.1001/jamapsychiatry.2024.3702
  2. U.S. Food and Drug Administration Are There "FDA Registered" or "FDA Certified" Medical Devices? How Do I Know What Is FDA Approved?. source
  3. U.S. Food and Drug Administration Product Classification. source
  4. Peak Brain Institute About Peak Brain Institute. source
  5. Peak Brain Institute Real Neurofeedback. Real QEEG Brain Maps. Done at Home.. source

Get new articles and brain training insights by email.

No spam, unsubscribe anytime.

About Dr. Andrew Hill

Dr. Andrew Hill is a neuroscientist, founder of Peak Brain Institute and host of the Head First podcast. He writes about neurofeedback, attention, learning and brain health.

Get Brain Coaching from Dr. Hill →

Get new articles and brain training insights by email.

No spam, unsubscribe anytime.